Amplification and/or over-expression of the human GAB2 gene has been also recently reported for ovarian [208] and gastric cancer [209] and acute myeloid leukemia (AML) [210], although additional functional studies are required to dissect the role that Gab2 plays in these malignancies. This evidence concerns the gene GAB2 and acute myeloid leukemia.